Genetic polymorphisms in obesity-related genes and endometrial cancer risk

Cancer

Volumn 118, Issue 13, 2012, Pages 3356-3364

  Chen, Xiaoli ^a,b   Xiang, Yong Bing ^c   Long, Ji Rong ^a   Cai, Hui ^a   Cai, Qiuyin ^a   Cheng, Jiarong ^c   Wen, Wanqing ^a   Gao, Yu Tang ^c   Zheng, Wei ^a   Shu, Xiao Ou ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c SHANGHAI CANCER INSTITUTE   (China)

Author keywords

Adipokine; Adiponectin; Endometrial cancer; Leptin; Obesity; Polymorphism

Indexed keywords

ADIPONECTIN; ADIPONECTIN RECEPTOR 1; ADIPONECTIN RECEPTOR 2; LEPTIN; LEPTIN RECEPTOR;

ADI POQ GENE; ADIPOR1 GENE; ADIPOR2 GENE; ADULT; ALLELE; ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY MASS; CALORIC INTAKE; CANCER RISK; CHINESE; COMMUNITY; CONTROLLED STUDY; ENDOMETRIUM CANCER; FEMALE; GENE; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENOTYPE; HIP CIRCUMFERENCE; HOMOZYGOSITY; HUMAN; LEP GENE; LEPR GENE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; OBESITY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; WAIST CIRCUMFERENCE;

ADIPONECTIN; ENDOMETRIAL NEOPLASMS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LEPTIN; MIDDLE AGED; OBESITY; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, ADIPONECTIN; RECEPTORS, LEPTIN; RISK FACTORS;

EID: 84862519959     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.26552     Document Type: Article

References (38)

1. American Cancer Society. Cancer facts & figures 2009. Available at: Accessed October 18, 2009.
2. Calle EE, Kaaks R,. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer. 2004; 4: 579-591. (Pubitemid 39025053)
3. Xu WH, Matthews CE, Xiang YB, et al. Effect of adiposity and fat distribution on endometrial cancer risk in Shanghai women. Am J Epidemiol. 2005; 161: 939-947. (Pubitemid 40656416)
4. Rasmussen-Torvik LJ, Pankow JS, Jacobs DR Jr, Steinberger J, Moran A, Sinaiko AR,. The association of SNPs in ADIPOQ, ADIPOR1, and ADIPOR2 with insulin sensitivity in a cohort of adolescents and their parents. Hum Genet. 2009; 125: 21-28.
5. Korner A, Pazaitou-Panayiotou K, Kelesidis T, et al. Total and high-molecular-weight adiponectin in breast cancer: in vitro and in vivo studies. J Clin Endocrinol Metab. 2007; 92: 1041-1048. (Pubitemid 46465681)
6. Dieudonne MN, Bussiere M, Dos Santos E, Leneveu MC, Giudicelli Y, Pecquery R,. Adiponectin mediates antiproliferative and apoptotic responses in human MCF7 breast cancer cells. Biochem Biophys Res Commun. 2006; 345: 271-279.
7. Jarde T, Caldefie-Chezet F, Goncalves-Mendes N, et al. Involvement of adiponectin and leptin in breast cancer: clinical and in vitro studies. Endocr Relat Cancer. 2009; 16: 1197-1210.
8. Soliman PT, Wu D, Tortolero-Luna G, et al. Association between adiponectin, insulin resistance, and endometrial cancer. Cancer. 2006; 106: 2376-2381. (Pubitemid 43787661)
9. Cust AE, Kaaks R, Friedenreich C, et al. Plasma adiponectin levels and endometrial cancer risk in pre- and postmenopausal women. J Clin Endocrinol Metab. 2007; 92: 255-263. (Pubitemid 46067541)
10. Dal Maso L, Augustin LS, Karalis A, et al. Circulating adiponectin and endometrial cancer risk. J Clin Endocrinol Metab. 2004; 89: 1160-1163. (Pubitemid 38368405)
11. Cymbaluk A, Chudecka-Glaz A, Rzepka-Gorska I,. Leptin levels in serum depending on body mass index in patients with endometrial hyperplasia and cancer. Eur J Obstet Gynecol Reprod Biol. 2008; 136: 74-77.
12. Petridou E, Belechri M, Dessypris N, et al. Leptin and body mass index in relation to endometrial cancer risk. Ann Nutr Metab. 2002; 46: 147-151. (Pubitemid 34920698)
13. Gallicchio L, McSorley MA, Newschaffer CJ, et al. Body mass, polymorphisms in obesity-related genes, and the risk of developing breast cancer among women with benign breast disease. Cancer Detect Prev. 2007; 31: 95-101. (Pubitemid 46669815)
14. Kaklamani VG, Sadim M, Hsi A, et al. Variants of the adiponectin and adiponectin receptor 1 genes and breast cancer risk. Cancer Res. 2008; 68: 3178-3184.
15. Cleveland RJ, Gammon MD, Long CM, et al. Common genetic variations in the LEP and LEPR genes, obesity and breast cancer incidence and survival. Breast Cancer Res Treat. 2010; 120: 745-752.
16. Ribeiro R, Vasconcelos A, Costa S, et al. Overexpressing leptin genetic polymorphism (-2548 G/A) is associated with susceptibility to prostate cancer and risk of advanced disease. Prostate. 2004; 59: 268-274. (Pubitemid 38509759)
17. Snoussi K, Strosberg AD, Bouaouina N, Ben Ahmed S, Helal AN, Chouchane L,. Leptin and leptin receptor polymorphisms are associated with increased risk and poor prognosis of breast carcinoma. BMC Cancer. 2006; 6: 38.
18. Woo HY, Park H, Ki CS, Park YL, Bae WG,. Relationships among serum leptin, leptin receptor gene polymorphisms, and breast cancer in Korea. Cancer Lett. 2006; 237: 137-142.
19. Teras LR, Goodman M, Patel AV, et al. No association between polymorphisms in LEP, LEPR, ADIPOQ, ADIPOR1, or ADIPOR2 and postmenopausal breast cancer risk. Cancer Epidemiol Biomarkers Prev. 2009; 18: 2553-2557.
20. Yapijakis C, Kechagiadakis M, Nkenke E, et al. Association of leptin -2548G/A and leptin receptor Q223R polymorphisms with increased risk for oral cancer. J Cancer Res Clin Oncol. 2009; 135: 603-612.
21. Slattery ML, Wolff RK, Herrick J, Caan BJ, Potter JD,. Leptin and leptin receptor genotypes and colon cancer: gene-gene and gene-lifestyle interactions. Int J Cancer. 2008; 122: 1611-1617. (Pubitemid 351294971)
22. Doecke JD, Zhao ZZ, Stark MS, et al. Single nucleotide polymorphisms in obesity-related genes and the risk of esophageal cancers. Cancer Epidemiol Biomarkers Prev. 2008; 17: 1007-1012. (Pubitemid 351536439)
23. Xu WH, Long JR, Zheng W, et al. Association of thymidylate synthase gene with endometrial cancer risk in a Chinese population. Cancer Epidemiol Biomarkers Prev. 2009; 18: 579-584.
24. Gao YT, Shu XO, Dai Q, et al. Association of menstrual and reproductive factors with breast cancer risk: results from the Shanghai Breast Cancer Study. Int J Cancer. 2005; 87: 295-300.
25. de Bakker PI, Yelensky R, Péer I, Gabriel SB, Daly MJ, Altshuler D,. Efficiency and power in genetic association studies. Nat Genet. 2005; 37: 1217-1223. (Pubitemid 41568704)
26. WHO/IASO/IOTF. The Asia-Pacific perspective: redefining obesity and its treatment. Sydney: Health Communications Australia Pty Limited; 2000.
27. Zhou BF,. Effect of body mass index on all-cause mortality and incidence of cardiovascular diseasesâreport for meta-analysis of prospective studies open optimal cut-off points of body mass index in Chinese adults. Biomed Environ Sci. 2002; 15: 245-252.
28. Carvajal-Carmona LG, Spain S, Kerr D, Houlston R, Cazier JB, Tomlinson I,. Common variation at the adiponectin locus is not associated with colorectal cancer risk in the UK. Hum Mol Genet. 2009; 18: 1889-1892.
29. Moore SC, Leitzmann MF, Albanes D, et al. Adipokine genes and prostate cancer risk. Int J Cancer. 2009; 124: 869-876.
30. Kaklamani VG, Wisinski KB, Sadim M, et al. Variants of the adiponectin (ADIPOQ) and adiponectin receptor 1 (ADIPOR1) genes and colorectal cancer risk. JAMA. 2008; 300: 1523-1531.
31. Han CZ, Du LL, Jing JX, et al. Associations among lipids, leptin, and leptin receptor gene Gin223Arg polymorphisms and breast cancer in China. Biol Trace Elem Res. 2008; 126: 38-48.
32. Pechlivanis S, Bermejo JL, Pardini B, et al. Genetic variation in adipokine genes and risk of colorectal cancer. Eur J Endocrinol. 2009; 160: 933-940.
33. Matthews CE, Xu WH, Zheng W, et al. Physical activity and risk of endometrial cancer: a report from the Shanghai endometrial cancer study. Cancer Epidemiol Biomarkers Prev. 2005; 14: 779-785. (Pubitemid 40478535)
34. Xu WH, Dai Q, Xiang YB, et al. Nutritional factors in relation to endometrial cancer: a report from a population-based case-control study in Shanghai, China. Int J Cancer. 2007; 120: 1776-1781. (Pubitemid 46399365)
35. Furberg AS, Thune I,. Metabolic abnormalities (hypertension, hyperglycemia and overweight), lifestyle (high energy intake and physical inactivity) and endometrial cancer risk in a Norwegian cohort. Int J Cancer. 2003; 104: 669-676. (Pubitemid 36418502)
36. Cust AE, Armstrong BK, Friedenreich CM, Slimani N, Bauman A,. Physical activity and endometrial cancer risk: a review of the current evidence, biologic mechanisms and the quality of physical activity assessment methods. Cancer Causes Control. 2007; 18: 243-258. (Pubitemid 46356210)
37. Olson SH, Trevisan M, Marshall JR, et al. Body mass index, weight gain, and risk of endometrial cancer. Nutr Cancer. 1995; 23: 141-149.
38. Chang S, Masse LC, Moser RP, et al. State ranks of incident cancer burden due to overweight and obesity in the United States, 2003. Obesity (Silver Spring). 2008; 16: 1636-1650. (Pubitemid 351915101)